News | March 06, 2014

BioZorb Surgical Marker Profiled at BC3 Breast Cancer Conference

Focal Therapeutics BioZorb Tumor Localization Women's Health Oncology Related

March 6, 2014 — The BioZorb 3-D surgical marker improved targeting for radiation therapy by enhancing visualization of the breast cancer lumpectomy cavity. This is according to a presentation at the 2014 Breast Cancer Coordinated Care (BC3) conference in Washington D.C.

The scientific poster reported that substantial advantages were observed when the tissue marker was used with both post-operative radiation boost therapy and partial breast irradiation (PBI).

The study, which involved 22 patients, compared the use of the 3-D tissue marker to traditional tissue landmarks such as seroma and clips as well as post-operative density changes seen on treatment planning CT scans.

"Overall, this tissue marker allowed us to achieve more than a 50 percent reduction in the planned treatment volume," said poster co-author Robert R. Kuske, Jr., M.D., a radiation oncologist at Arizona Breast Cancer Specialists. "With the BioZorb in place we didn't have the guesswork that we have with traditional markers, so we had confidence that we were only irradiating the minimum tissue necessary. This means better results for our patients and also less risk to healthy tissue near the surgical cavity."

Besides the improvement in target volume delineation, the researchers reported that all patients tolerated placement of BioZorb without complications and cosmetic outcomes were excellent.

Previously, there was no standardized method for marking the surgical site of tumor removal, which made post-operative radiation planning difficult. Methods typically used for radiation planning may overestimate the treatment area volume, and may result in excess radiation exposure to normal tissues such as the heart and lungs. This can cause inadvertent complications. 

The open-spiral design of the BioZorb marker incorporates six permanent titanium clips in a fixed 3-D array and provides specific landmarks at the site of the excised tumor. This poster indicates BioZorb marker as useful for radiation treatment planning, patient positioning during treatment and the ability to facilitate advanced methods of radiation treatment, such as respiratory gating.

BioZorb has been used successfully in the United States and New Zealand. It is made of a bioabsorbable material commonly used in other medical devices. It allows the patient's body to absorb the material slowly, so it does not require surgical removal after treatments are completed.

BioZorb received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The device is available in a range of sizes to accommodate a variety of clinical situations.

For more information: www.focalrx.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Breast Cancer Survivors Not Getting Recommended Number of Mammograms Post-Surgery
News | Mammography | May 24, 2018
Breast cancer survivors are not getting the recommended level of screening post-surgery, according to a newly-published...
Breast Cancer Places Greater Financial Burden on Black Women
News | Women's Health | May 16, 2018
Having breast cancer placed a significantly greater financial strain on black women than white women, according to a...
FDA's MQSA Accreditation Bodies Approved for Tomosynthesis Accreditation

Image courtesy of Fujifilm.

Feature | Mammography | May 14, 2018
On April 9, 2018, the U.S. Food and Drug Administration (FDA) announced that all four of its Mammography Quality...
Overlay Init